Literature DB >> 23062009

Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice.

Roopali Rajput1, Madhu Khanna, Prashant Kumar, Binod Kumar, Sonal Sharma, Neha Gupta, Latika Saxena.   

Abstract

Nonstructural protein 1 (NS1) of influenza A viruses counteracts the host immune response against the influenza viruses by not only inhibiting the nuclear export and maturation of host cell messenger RNA (mRNA), but by also blocking the double-stranded RNA-activated protein kinase-mediated inhibition of viral RNA translation. Reduction of NS1 gene product in the host cell may be a potent antiviral strategy to provide protection against the influenza virus infection. We used small interfering RNAs (siRNAs) synthesized against the viral mRNA to down regulate the NS1 gene and observed its effect on inhibition of virus replication. When NS1 gene-specific siRNA were transfected in Madin Darby canine kidney (MDCK) cells followed by influenza A virus infection, approximately 60% inhibition in intracellular levels of NS1 RNA was observed. When siRNA was administered in BALB/c mice, 92% reduction in the levels of NS1 gene expression in mice lungs was observed. A significant reduction in the lung virus titers and cytokine levels was also detected in the presence of siRNAs as compared with the untreated control. The study was validated by the use of selectively disabled mutants of each set of siRNA. Our findings suggest that siRNA targeted against NS1 gene of influenza A virus can provide considerable protection to the virus-infected host cells and may be used as potential candidates for nucleic acid-based antiviral therapy for prevention of influenza A virus infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062009     DOI: 10.1089/nat.2012.0359

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  8 in total

Review 1.  The influenza virus NS1 protein as a therapeutic target.

Authors:  Daniel A Engel
Journal:  Antiviral Res       Date:  2013-06-21       Impact factor: 5.970

2.  Potent Intracellular Knock-Down of Influenza A Virus M2 Gene Transcript by DNAzymes Considerably Reduces Viral Replication in Host Cells.

Authors:  Binod Kumar; Roopali Rajput; Dibya Ranjan Pati; Madhu Khanna
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

3.  Cross-protective effect of antisense oligonucleotide developed against the common 3' NCR of influenza A virus genome.

Authors:  Prashant Kumar; Binod Kumar; Roopali Rajput; Latika Saxena; Akhil C Banerjea; Madhu Khanna
Journal:  Mol Biotechnol       Date:  2013-11       Impact factor: 2.695

4.  Biochemical and structural characterization of the interface mediating interaction between the influenza A virus non-structural protein-1 and a monoclonal antibody.

Authors:  Jianping Wu; Chee-Keng Mok; Vincent Tak Kwong Chow; Y Adam Yuan; Yee-Joo Tan
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

5.  In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery.

Authors:  Daniel Tsung-Ning Huang; Chun-Yi Lu; Pei-Lan Shao; Luan-Yin Chang; Jin-Yuan Wang; Yi-Hsuan Chang; Mei-Ju Lai; Ya-Hui Chi; Li-Min Huang
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

6.  Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.

Authors:  Cuiling Zhang; Weigang Ren; Qingxin Liu; Zhikai Tan; Junwei Li; Chunyi Tong
Journal:  Drug Des Devel Ther       Date:  2019-04-04       Impact factor: 4.162

7.  H5N1 infection causes rapid mortality and high cytokine levels in chickens compared to ducks.

Authors:  Simon Burggraaf; Adam J Karpala; John Bingham; Sue Lowther; Paul Selleck; Wayne Kimpton; Andrew G D Bean
Journal:  Virus Res       Date:  2014-03-19       Impact factor: 3.303

Review 8.  The Central Role of Non-Structural Protein 1 (NS1) in Influenza Biology and Infection.

Authors:  Nícia Rosário-Ferreira; António J Preto; Rita Melo; Irina S Moreira; Rui M M Brito
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.